In addition, an exploration of TGF-β pathway genes (SMAD2 and TGFBR2) found significant associations with MetS and its traits, emphasizing gene–gene interactions affecting MetS risk [63]. This evidence concerns the gene SMAD2 and metabolic syndrome.